---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-007109"
form_type: "8-K"
ticker: "BLGO"
cik: "0000880242"
company_name: "BIOLARGO, INC."
filed_at: "2022-03-24T23:59:59+00:00"
generated_at: "2026-06-26T19:06:31.439500+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BioLargo extends CFO engagement through Jan 2023; grants 300k-share option at $0.24

## Summary
- CFO Charles K. Dargan II engagement extended one year to January 31, 2023.
- Sole compensation: option to purchase 300,000 shares (25,000/month) at $0.24 per share.
- Option vests monthly beginning March 2022; no cash compensation for the term.
- Option granted under 2018 Equity Incentive Plan, expires ten years from grant date.
- Either party can terminate the agreement with 30 days' written notice.

## SEC filing metadata
- accession: 0001437749-22-007109
- form_type: 8-K
- ticker: BLGO
- cik: 0000880242
- company_name: BIOLARGO, INC.
- filed_at: 2022-03-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/0001437749-22-007109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/blgo20220323_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-007109
- JSON: https://secwatch.observer/filing/0001437749-22-007109.json
- Plain text: https://secwatch.observer/filing/0001437749-22-007109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.